Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
Clinical trial NCT00783692 · COMPLETED
Trial details
- NCT number
- NCT00783692
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2012-03-01
- Enrollment
- 1116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.